1592-P: Parent Report of Housing and Economic Strain: Impact on Diabetes Distress in Adolescents with Type 1 Diabetes

Introduction and Objective: Health-related social needs (HRSN) can influence type 1 diabetes (T1D) management, affecting outcomes and quality of life. Limited research examines how family HRSN relates to diabetes distress in adolescents with T1D. This study examined associations between parent-reported HRSN and adolescent-reported diabetes distress. Methods: A cross-sectional survey with a convenience sample of parents and their adolescents (10-18yrs) attending T1D camps/conferences assessed parent report of income, economic pressure, housing stability, community size/type and adolescent report of diabetes distress (PAID-Y). One-way ANOVAs examined PAID-Y mean differences across HRSN response categories (income, housing, geography). Pearson correlations assessed age and disease duration associations with PAID-Y scores. Results: Among 90 parent/adolescent response means, adolescent age was 12.66 (± 1.88) years, HbA1c was 7.54% (±1.30%), and years since diagnosis was 5.21 (± 3.43). For parent HRSN responses, 31.20% reported income <$80,000, 93.80% reported difficulty paying bills, 56.20% reported ‘some’ to ‘great’ difficulty maintaining stable housing, and 51.40% being from rural or small urban communities. Mean PAID-Y score was 52.12 (± 20.91) on 0-100 scale; 20-25% reported ‘moderate’ to ‘very serious distress’ on ≥1 item. Differences in mean PAID-Y were statistically significant across parent report of housing instability F(4,85) =2.70, p=0.036; higher level of housing difficulty had adolescents reporting higher PAID-Y. Mean PAID-Y differences were not significant across income and geography categories nor age or disease duration correlations. Conclusion: Adolescent diabetes distress was significantly associated with parent housing stability worries, supporting the need for HRSN screening and referral to address modifiable family barriers to psychological well-being in adolescent T1D. Disclosure H. Hamzat: None. J. Kavookjian: Consultant; Current; Aspen Pharmacare. Consultant; Ended; MannKind Corporation. Consultant; Current; Association of Diabetes Care & Education Specialists, Breakthrough T1D.